Literature DB >> 7957365

Severe mental retardation in a young boy with an in-frame deletion in the dystrophin gene.

J Colomer1, P Gallano, L V Nicholson, E Tizzano, M Baiget.   

Abstract

We report here a mentally retarded 32-month-old boy whose initial diagnosis was Angelman syndrome based on his clinical features. Cytogenetic studies showed a normal karyotype. Due to an elevated level of serum creatine kinase activity, we performed analyses to rule out a myopathic process. Although the electromyogram was normal, a few scattered necrotic fibres were seen in the muscle biopsy. DNA and dystrophin studies revealed an in-frame deletion in the 5' region of the dystrophin gene and an abnormal form of the protein product, consistent with a diagnosis of dystrophinopathy. We cannot totally rule out the possibility that this boy has the two separate conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957365     DOI: 10.1007/BF01957003

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  Cytogenetic and molecular study of Angelman syndrome.

Authors:  K Imaizumi; F Takada; Y Kuroki; K Naritomi; J Hamabe; N Niikawa
Journal:  Am J Med Genet       Date:  1990-03

2.  Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction.

Authors:  A H Beggs; M Koenig; F M Boyce; L M Kunkel
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

3.  Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis.

Authors:  R Gold; W Kress; B Meurers; G Meng; H Reichmann; C R Müller
Journal:  Muscle Nerve       Date:  1992-02       Impact factor: 3.217

4.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.

Authors:  K M Bushby; D Gardner-Medwin; L V Nicholson; M A Johnson; I D Haggerty; N J Cleghorn; J B Harris; S S Bhattacharya
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

5.  Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody.

Authors:  L V Nicholson; K Davison; G Falkous; C Harwood; E O'Donnell; C R Slater; J B Harris
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

6.  Becker muscular dystrophy or spinal muscular atrophy?--Dystrophin studies resolve conflicting results of electromyography and muscle biopsy.

Authors:  T D McDonald; R Medori; D S Younger; H W Chang; C Minetti; A Uncini; E Bonilla; A P Hays; R E Lovelace
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

7.  Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.

Authors:  F Muntoni; A Mateddu; C Cianchetti; M G Marrosu; A Clerk; M Cau; R Congiu; A Cao; M A Melis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

8.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

Authors:  A H Beggs; E P Hoffman; J R Snyder; K Arahata; L Specht; F Shapiro; C Angelini; H Sugita; L M Kunkel
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.